CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 335 enrolled
Drug / intervention
CHG 2% w/v & IPA 70% v/v, swabstick (3 @ once). +4 moredrug
Likely dose
Aqueous CHG 4% w/v applied according to mfr's directions 5 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00799812
NCT00799812Phase 3Completed
CompareCT.gov

Test for Pre Operative Skin Preparations: ChloraPrep Triple Swabsticks, Hibiclens and Sterile Triple Swabsticks (Using Sterile Deionized Water)

C. R. Bard·interventional·Posted Dec 1, 2008·Updated Dec 11, 2025

In Brief

A Phase 3 clinical trial evaluating CHG 2% w/v & IPA 70% v/v, swabstick (3 @ once)., CHG 2% w/v & IPA 70% v/v swab applied sequentially, and 3 other interventions for Topical Antisepsis. Completed, enrolled 335 participants across 1 site.

Detailed Summary

Compare 2 application techniques of ChloraPrep Swabstick--3 swabsticks at once versus 3 swabsticks used sequentially. Hibiclens applied according to the manufacturer's directions. Sterile swabsticks (wetted with sterile deionizd water) applied using the same method as the ChloraPrep Swabstick.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTopical Antisepsis
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 1, 2008
Enrollment StartNov 13, 2007
Primary CompletionApr 27, 2008
Study CompletionJun 19, 2008
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 17.6 years ago

Interventions

CHG 2% w/v & IPA 70% v/v, swabstick (3 @ once).drug

3 swabsticks topically applied at the same time to intact skin

CHG 2% w/v & IPA 70% v/v swab applied sequentiallydrug

Chlorhexidine gluconate 2% w/v and isopropyl alcohol 70% v/v; 3 swabsticks applied sequentially to intact skin.

Aqueous CHG 4% w/v applied according to mfr's directionsdrug

Chlorhexidine gluconate 4% w/v in an aqueous base applied according to mfr's directions. Step 1) 5 ml of Hibiclens applied to a sterile gauze pad. Step 2) Product applied to treatment area on intact skin for 2 minutes. Area dried with sterile towel or sterile gauze. Steps 1 and 2 repeated.

Sterile swabstick with sterile water (3 @ once)other

3 sterile swabsticks wetted with sterile water topically applied to intact skin at the same time.

Sterile swabstick with sterile water (one-at-a-time)other

Sterile swabsticks wetted with sterile water topically applied to intact skin one-at-a-time.